Common mental disorders within chronic inflammatory disorders: a primary care database prospective investigation.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
05 2019
Historique:
received: 31 10 2018
revised: 24 01 2019
accepted: 17 02 2019
pubmed: 9 3 2019
medline: 31 12 2019
entrez: 9 3 2019
Statut: ppublish

Résumé

There is inconsistent evidence about the association between inflammatory disorders and depression and anxiety onset in a primary care context. The study aimed to evaluate the risk of depression and anxiety within multisystem and organ-specific inflammatory disorders. This is a prospective cohort study with primary care patients from the UK Clinical Practice Research Datalink diagnosed with an inflammatory disorder between 1 January 2001 and 31 December 2016. These patients were matched on age, gender, practice and index date with patients without an inflammatory disorder. The study exposures were seven chronic inflammatory disorders. Clinical diagnosis of depression and anxiety represented the outcome measures of interest. Among 538 707 participants, the incidence of depression ranged from 14 per 1000 person-years (severe psoriasis) to 9 per 1000 person-years (systemic vasculitis), substantively higher compared with their comparison group (5-7 per 1000 person-years). HRs of multiple depression and anxiety events were 16% higher within inflammatory disorders (HR, 1.16, 95% CI 1.12 to 1.21, p<0.001) compared with the matched comparison group. The incidence of depression and anxiety was strongly associated with the age at inflammatory disorder onset. The overall HR estimate for depression was 1.90 (95% CI 1.66 to 2.17, p<0.001) within early-onset disorder (<40 years of age) and 0.93 (95% CI 0.90 to 1.09, p=0.80) within late-onset disorder (≥60 years of age). Primary care patients with inflammatory disorders have elevated rates of depression and anxiety incidence, particularly those patients with early-onset inflammatory disorders. This finding may reflect the impact of the underlying disease on patients' quality of life, although the precise mechanisms require further investigation.

Identifiants

pubmed: 30846444
pii: annrheumdis-2018-214676
doi: 10.1136/annrheumdis-2018-214676
doi:

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-695

Subventions

Organisme : Medical Research Council
ID : G108/603
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17214
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J002739/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N029488/1
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Alexandru Dregan (A)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK alexandru.dregan@kcl.ac.uk.

Faith Matcham (F)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Lisa Harber-Aschan (L)

Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Lauren Rayner (L)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Anamaria Brailean (A)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Katrina Davis (K)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Stephani Hatch (S)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Carmine Pariante (C)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

David Armstrong (D)

School of Population Health & Environmental Sciences, King's College London, London, UK.

Robert Stewart (R)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust, London, UK.

Matthew Hotopf (M)

Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London and Maudsley NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH